Please login to the form below

Not currently logged in
Email:
Password:

first-in-human

This page shows the latest first-in-human news and features for those working in and with pharma, biotech and healthcare.

FDA lifts hold on Vertex and CRISPR Therapeutics sickle cell therapy

FDA lifts hold on Vertex and CRISPR Therapeutics sickle cell therapy

The US regulator placed a hold on the trial in May, which could now become the first in human trials of the CRISPR technology. ... produce high levels of foetal haemoglobin (HbF; haemoglobin F) in red blood cells.

Latest news

  • A look ahead to key trial readouts at ESMO A look ahead to key trial readouts at ESMO

    In immuno-oncology, this year’s offering includes a first showing for data in first-line advanced renal cell carcinoma for Merck KGaA/Pfizer’s Bavencio (avelumab) in the JAVELIN Renal ... Looking at some of the new mechanisms on show, Merck/MSD will

  • Darzalex powers ahead with frontline myeloma approval in Europe Darzalex powers ahead with frontline myeloma approval in Europe

    It’s all the more remarkable considering it has only been ten years since the first dose of daratumumab was administered in the earliest human studies,” said Dr Torben Plesner, the ... first investigator to administer daratumumab in human trials and

  • Pfizer signs mRNA flu vaccine deal with BioNTech Pfizer signs mRNA flu vaccine deal with BioNTech

    they pass the phase I first-in-human clinical trial stage. ... first human trial of a freeze-dried mRNA vaccine candidate.

  • DNA damage specialists Artios Pharma raises $84m DNA damage specialists Artios Pharma raises $84m

    They are now developing a pipeline of first-in-class DDR therapies targeting novel DNA repair targets like Pol θ, in tumours where DNA damage response factors have been lost or ... The company says it aims to initiate a first-in-human clinical study of

  • FDA delays verdict on Roche's MS drug Ocrevus FDA delays verdict on Roche's MS drug Ocrevus

    Ocrevus  is the first investigational medicine with the potential to treat both forms, outperforming Merck KGaA's Rebif (interferon beta-1a) in the two relapsing multiple sclerosis phase III trials and ... Roche is now due to hear from the FDA by 28

More from news
Approximately 1 fully matching, plus 28 partially matching documents found.

Latest Intelligence

  • 30 Women Leaders in UK Healthcare 30 Women Leaders in UK Healthcare

    for Lynparza, the first in class PARP inhibitor now approved in ovarian and breast cancers. ... treatments for first-in-human trials.

  • Pharma deals in August 2015 Pharma deals in August 2015

    First mooted in December 2014, the companies had entered into a broad strategic alliance covering a five year period as part of an open innovation initiative. ... As the first approved product for this disorder the US launch is expected in October.

  • The balance of power in healthcare The balance of power in healthcare

    Parsa said: “For the first time in human history we can do with your body what we are already doing with your car, which is continuously checking the engine before moving ... For the first time in history, people will have the 'check engine' capability

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Industry appointments Industry appointments

    Greenberg brings more than 35 years to Allergan’s board and this appointment marks the fifth new director in 18 months. ... Most recently, Hassan built the oncology-focused biology, preclinical and biomarker units for Immunocore, overseeing early

  • Swiss biotech Inositec appoints new chief medical officer Swiss biotech Inositec appoints new chief medical officer

    These innovative products have the potential to significantly advance patient care in vascular and other calcification disorders, all with high unmet medical need.”. ... in the vascular calcification space and fine-tune our clinical strategy in view of

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Packer Forbes News April 2016

    Hannah graduated with first class honours in Human Biology from the University of Birmingham. ... We have made our annual charity clothes donation in aid of Multiple Sclerosis Research.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health Communications

Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics